Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	89.83	-51.15	-503.07
Graham Fair Price	45.04	5.19	3.58
PEG	-93.90	-0.10	1.67
Price/Book	-9.79	4.89	5.42
Price/Cash Flow	83.55	-17.02	-103.50
Prices/Earnings	62.72	-13.82	-37.07
Price/Sales	26.19	21.34	16.91
Price/FCF	83.55	-17.02	-103.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	-61.06	-0.19	-0.12
Operating Margin	-289.17	-0.52	-0.13
ROA	-125.40	-0.04	-0.02
ROE	-0.04	-0.09	-141.98
ROIC	-0.03	-0.06	-138.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	0.10	0.47	-79.07
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.28	-1.60	462.90
EPS QOQ	0.22	-1.36	510.71
FCF QOQ	0.79	-4.13	426.04
Revenue QOQ	0.76	-0.33	-56.48
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	16.02	17.78	10.96
Days Sales Outstanding (DSO)	181.02	335.20	85.17
Inventory Turnover	5.62	5.06	-9.88
Debt/Capitalization	0.26	0.30	12.89
Quick Ratio	1.99	1.60	-19.44
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	3.95	3.68	-6.76
Cash	2.01	1.04	-48.36
Capex	-0.47	-0.44	4.74
Free Cash Flow	-0.21	-1.06	-411.46
Revenue	1.27	0.84	-33.35
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	2.11	1.68	-20.06
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.78	-1.61	-87.40
Naive Interpretation	Member

06 - Financial Health · Weak

Rating